Company Analysis Kontour (Xi'an) Medical Technology Co., Ltd.
1. Summary
Advantages
- Dividends (1.7%) are higher than the sector average (0%).
Disadvantages
- Price (23.19 Β₯) is higher than fair price (10.22 Β₯)
- The stock's return over the last year (-11.64%) is lower than the sector average (5.46%).
- The company's current efficiency (ROE=13.36%) is lower than the sector average (ROE=93.38%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Kontour (Xi'an) Medical Technology Co., Ltd. | Index | ||
|---|---|---|---|
| 7 days | -2.4% | -1.7% | 3.8% |
| 90 days | 0.6% | -4.8% | 22.6% |
| 1 year | -11.6% | 5.5% | 42.3% |
688314 vs Sector: Kontour (Xi'an) Medical Technology Co., Ltd. has significantly underperformed the "" sector by -17.1% over the past year.
688314 vs Market: Kontour (Xi'an) Medical Technology Co., Ltd. has significantly underperformed the market by -53.9% over the past year.
Stable price: 688314 is not significantly more volatile than the rest of the market on "Shanghai Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 688314 with weekly volatility of -0.2238% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (23.19 Β₯) is higher than the fair price (10.22 Β₯).
Price is higher than fair: The current price (23.19 Β₯) is 55.9% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (33.83) is higher than that of the sector as a whole (5.77).
P/E vs Market: The company's P/E (33.83) is lower than that of the market as a whole (64.64).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.36) is higher than that of the sector as a whole (3.84).
P/BV vs Market: The company's P/BV (4.36) is higher than that of the market as a whole (3.08).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (9.29) is higher than that of the sector as a whole (4.05).
P/S vs Market: The company's P/S indicator (9.29) is higher than that of the market as a whole (6.41).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is lower than that of the sector as a whole (17.14).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is lower than that of the market as a whole (17.31).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 8.83% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (8.83%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
5.4. ROE
ROE vs Sector: The company's ROE (13.36%) is lower than that of the sector as a whole (93.38%).
ROE vs Market: The company's ROE (13.36%) is higher than that of the market as a whole (8.24%).
5.5. ROA
ROA vs Sector: The company's ROA (11.49%) is lower than that of the sector as a whole (83.44%).
ROA vs Market: The company's ROA (11.49%) is higher than that of the market as a whole (4.08%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 1.7% is higher than the average for the sector '0%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.7% has been steadily paid over the past 7 years, DSI=0.9.
Weak dividend growth: The company's dividend yield 1.7% has been growing weakly or stagnant over the past 5 years. Growth over only 3 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (42.15%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
